mdxhealth’s Post

View organization page for mdxhealth, graphic

6,819 followers

In 2020, Cullen et al. demonstrated that Genomic Prostate Score was a strong predictor of biochemical recurrence, distant metastasis, and prostate cancer specific death in patients with intermediate-risk prostate cancer.

To view or add a comment, sign in

Explore topics